Page last updated: 2024-08-23

cetylpyridinium chloride anhydrous and Biliary Tract Diseases

cetylpyridinium chloride anhydrous has been researched along with Biliary Tract Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
LaRusso, NF; O'Hara, SP; Tabibian, JH; Varghese, C1

Reviews

1 review(s) available for cetylpyridinium chloride anhydrous and Biliary Tract Diseases

ArticleYear
The enteric microbiome in hepatobiliary health and disease.
    Liver international : official journal of the International Association for the Study of the Liver, 2016, Volume: 36, Issue:4

    Topics: Animals; Biliary Tract; Biliary Tract Diseases; Gastrointestinal Microbiome; Health; Host-Pathogen Interactions; Humans; Inflammation Mediators; Intestines; Liver; Liver Diseases; Microbiota; Signal Transduction

2016